{"transactions":[{"id":831933,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":56793,"kind":"person","name":"Aranda Richard","position":1,"cik":"0001867872","reported_name":"Aranda Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-20T20:22:00.000Z","date":"2026-03-19","kind":"grant","planned":false,"acquired":true,"shares":30000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Effective as of March 19, 2026 (the \"Repricing Date\"), the Issuer approved a one-time repricing of certain outstanding stock options (the \"Repriced Options\") granted under the Issuer's 2019 Incentive Award Plan (the \"2019 Plan\"), which reduced the per share exercise price of each Repriced Option to $0.45 (the \"Option Repricing\"). Except as modified by the Option Repricing, all other terms and conditions of the Repriced Options, including, without limitation, any provisions with respect to vesting and term of the Repriced Options, remain in full force and effect."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Effective as of March 19, 2026 (the \"Repricing Date\"), the Issuer approved a one-time repricing of certain outstanding stock options (the \"Repriced Options\") granted under the Issuer's 2019 Incentive Award Plan (the \"2019 Plan\"), which reduced the per share exercise price of each Repriced Option to $0.45 (the \"Option Repricing\"). Except as modified by the Option Repricing, all other terms and conditions of the Repriced Options, including, without limitation, any provisions with respect to vesting and term of the Repriced Options, remain in full force and effect."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the 2019 Plan and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form 4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":30000,"derivative":{"exercise_price":0.45,"expiration_date":"2029-03-25","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001867872-26-000004","document":"wk-form4_1774038115.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":24,"url":"https://www.sec.gov/Archives/edgar/data/1728117/000186787226000004/wk-form4_1774038115.xml","form_type":"4"}},{"id":831932,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":56793,"kind":"person","name":"Aranda Richard","position":1,"cik":"0001867872","reported_name":"Aranda Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-20T20:22:00.000Z","date":"2026-03-19","kind":"grant","planned":false,"acquired":true,"shares":9167,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Effective as of March 19, 2026 (the \"Repricing Date\"), the Issuer approved a one-time repricing of certain outstanding stock options (the \"Repriced Options\") granted under the Issuer's 2019 Incentive Award Plan (the \"2019 Plan\"), which reduced the per share exercise price of each Repriced Option to $0.45 (the \"Option Repricing\"). Except as modified by the Option Repricing, all other terms and conditions of the Repriced Options, including, without limitation, any provisions with respect to vesting and term of the Repriced Options, remain in full force and effect."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Effective as of March 19, 2026 (the \"Repricing Date\"), the Issuer approved a one-time repricing of certain outstanding stock options (the \"Repriced Options\") granted under the Issuer's 2019 Incentive Award Plan (the \"2019 Plan\"), which reduced the per share exercise price of each Repriced Option to $0.45 (the \"Option Repricing\"). Except as modified by the Option Repricing, all other terms and conditions of the Repriced Options, including, without limitation, any provisions with respect to vesting and term of the Repriced Options, remain in full force and effect."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the 2019 Plan and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form 4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":9167,"derivative":{"exercise_price":0.45,"expiration_date":"2029-12-23","underlying":"Common Stock","underlying_shares":9167},"source":{"system":"sec-edgar","filing":"0001867872-26-000004","document":"wk-form4_1774038115.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":23,"url":"https://www.sec.gov/Archives/edgar/data/1728117/000186787226000004/wk-form4_1774038115.xml","form_type":"4"}},{"id":831931,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":56793,"kind":"person","name":"Aranda Richard","position":1,"cik":"0001867872","reported_name":"Aranda Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-20T20:22:00.000Z","date":"2026-03-19","kind":"grant","planned":false,"acquired":true,"shares":22784,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Effective as of March 19, 2026 (the \"Repricing Date\"), the Issuer approved a one-time repricing of certain outstanding stock options (the \"Repriced Options\") granted under the Issuer's 2019 Incentive Award Plan (the \"2019 Plan\"), which reduced the per share exercise price of each Repriced Option to $0.45 (the \"Option Repricing\"). Except as modified by the Option Repricing, all other terms and conditions of the Repriced Options, including, without limitation, any provisions with respect to vesting and term of the Repriced Options, remain in full force and effect."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Effective as of March 19, 2026 (the \"Repricing Date\"), the Issuer approved a one-time repricing of certain outstanding stock options (the \"Repriced Options\") granted under the Issuer's 2019 Incentive Award Plan (the \"2019 Plan\"), which reduced the per share exercise price of each Repriced Option to $0.45 (the \"Option Repricing\"). Except as modified by the Option Repricing, all other terms and conditions of the Repriced Options, including, without limitation, any provisions with respect to vesting and term of the Repriced Options, remain in full force and effect."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the 2019 Plan and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form 4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":22784,"derivative":{"exercise_price":0.45,"expiration_date":"2030-02-14","underlying":"Common Stock","underlying_shares":22784},"source":{"system":"sec-edgar","filing":"0001867872-26-000004","document":"wk-form4_1774038115.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":22,"url":"https://www.sec.gov/Archives/edgar/data/1728117/000186787226000004/wk-form4_1774038115.xml","form_type":"4"}},{"id":831930,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":56793,"kind":"person","name":"Aranda Richard","position":1,"cik":"0001867872","reported_name":"Aranda Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-20T20:22:00.000Z","date":"2026-03-19","kind":"grant","planned":false,"acquired":true,"shares":40000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Effective as of March 19, 2026 (the \"Repricing Date\"), the Issuer approved a one-time repricing of certain outstanding stock options (the \"Repriced Options\") granted under the Issuer's 2019 Incentive Award Plan (the \"2019 Plan\"), which reduced the per share exercise price of each Repriced Option to $0.45 (the \"Option Repricing\"). Except as modified by the Option Repricing, all other terms and conditions of the Repriced Options, including, without limitation, any provisions with respect to vesting and term of the Repriced Options, remain in full force and effect."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Effective as of March 19, 2026 (the \"Repricing Date\"), the Issuer approved a one-time repricing of certain outstanding stock options (the \"Repriced Options\") granted under the Issuer's 2019 Incentive Award Plan (the \"2019 Plan\"), which reduced the per share exercise price of each Repriced Option to $0.45 (the \"Option Repricing\"). Except as modified by the Option Repricing, all other terms and conditions of the Repriced Options, including, without limitation, any provisions with respect to vesting and term of the Repriced Options, remain in full force and effect."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the 2019 Plan and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form 4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":40000,"derivative":{"exercise_price":0.45,"expiration_date":"2031-02-25","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001867872-26-000004","document":"wk-form4_1774038115.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":21,"url":"https://www.sec.gov/Archives/edgar/data/1728117/000186787226000004/wk-form4_1774038115.xml","form_type":"4"}},{"id":831929,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":56793,"kind":"person","name":"Aranda Richard","position":1,"cik":"0001867872","reported_name":"Aranda Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-20T20:22:00.000Z","date":"2026-03-19","kind":"grant","planned":false,"acquired":true,"shares":20000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Effective as of March 19, 2026 (the \"Repricing Date\"), the Issuer approved a one-time repricing of certain outstanding stock options (the \"Repriced Options\") granted under the Issuer's 2019 Incentive Award Plan (the \"2019 Plan\"), which reduced the per share exercise price of each Repriced Option to $0.45 (the \"Option Repricing\"). Except as modified by the Option Repricing, all other terms and conditions of the Repriced Options, including, without limitation, any provisions with respect to vesting and term of the Repriced Options, remain in full force and effect."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Effective as of March 19, 2026 (the \"Repricing Date\"), the Issuer approved a one-time repricing of certain outstanding stock options (the \"Repriced Options\") granted under the Issuer's 2019 Incentive Award Plan (the \"2019 Plan\"), which reduced the per share exercise price of each Repriced Option to $0.45 (the \"Option Repricing\"). Except as modified by the Option Repricing, all other terms and conditions of the Repriced Options, including, without limitation, any provisions with respect to vesting and term of the Repriced Options, remain in full force and effect."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the 2019 Plan and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form 4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":20000,"derivative":{"exercise_price":0.45,"expiration_date":"2031-06-21","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001867872-26-000004","document":"wk-form4_1774038115.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":20,"url":"https://www.sec.gov/Archives/edgar/data/1728117/000186787226000004/wk-form4_1774038115.xml","form_type":"4"}},{"id":831928,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":56793,"kind":"person","name":"Aranda Richard","position":1,"cik":"0001867872","reported_name":"Aranda Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-20T20:22:00.000Z","date":"2026-03-19","kind":"grant","planned":false,"acquired":true,"shares":126667,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Effective as of March 19, 2026 (the \"Repricing Date\"), the Issuer approved a one-time repricing of certain outstanding stock options (the \"Repriced Options\") granted under the Issuer's 2019 Incentive Award Plan (the \"2019 Plan\"), which reduced the per share exercise price of each Repriced Option to $0.45 (the \"Option Repricing\"). Except as modified by the Option Repricing, all other terms and conditions of the Repriced Options, including, without limitation, any provisions with respect to vesting and term of the Repriced Options, remain in full force and effect."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Effective as of March 19, 2026 (the \"Repricing Date\"), the Issuer approved a one-time repricing of certain outstanding stock options (the \"Repriced Options\") granted under the Issuer's 2019 Incentive Award Plan (the \"2019 Plan\"), which reduced the per share exercise price of each Repriced Option to $0.45 (the \"Option Repricing\"). Except as modified by the Option Repricing, all other terms and conditions of the Repriced Options, including, without limitation, any provisions with respect to vesting and term of the Repriced Options, remain in full force and effect."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the 2019 Plan and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form 4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":126667,"derivative":{"exercise_price":0.45,"expiration_date":"2032-01-05","underlying":"Common Stock","underlying_shares":126667},"source":{"system":"sec-edgar","filing":"0001867872-26-000004","document":"wk-form4_1774038115.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":19,"url":"https://www.sec.gov/Archives/edgar/data/1728117/000186787226000004/wk-form4_1774038115.xml","form_type":"4"}},{"id":831927,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":56793,"kind":"person","name":"Aranda Richard","position":1,"cik":"0001867872","reported_name":"Aranda Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-20T20:22:00.000Z","date":"2026-03-19","kind":"grant","planned":false,"acquired":true,"shares":157500,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Effective as of March 19, 2026 (the \"Repricing Date\"), the Issuer approved a one-time repricing of certain outstanding stock options (the \"Repriced Options\") granted under the Issuer's 2019 Incentive Award Plan (the \"2019 Plan\"), which reduced the per share exercise price of each Repriced Option to $0.45 (the \"Option Repricing\"). Except as modified by the Option Repricing, all other terms and conditions of the Repriced Options, including, without limitation, any provisions with respect to vesting and term of the Repriced Options, remain in full force and effect."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Effective as of March 19, 2026 (the \"Repricing Date\"), the Issuer approved a one-time repricing of certain outstanding stock options (the \"Repriced Options\") granted under the Issuer's 2019 Incentive Award Plan (the \"2019 Plan\"), which reduced the per share exercise price of each Repriced Option to $0.45 (the \"Option Repricing\"). Except as modified by the Option Repricing, all other terms and conditions of the Repriced Options, including, without limitation, any provisions with respect to vesting and term of the Repriced Options, remain in full force and effect."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the 2019 Plan and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form 4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":157500,"derivative":{"exercise_price":0.45,"expiration_date":"2032-12-06","underlying":"Common Stock","underlying_shares":157500},"source":{"system":"sec-edgar","filing":"0001867872-26-000004","document":"wk-form4_1774038115.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/1728117/000186787226000004/wk-form4_1774038115.xml","form_type":"4"}},{"id":831926,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":56793,"kind":"person","name":"Aranda Richard","position":1,"cik":"0001867872","reported_name":"Aranda Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-20T20:22:00.000Z","date":"2026-03-19","kind":"grant","planned":false,"acquired":true,"shares":157500,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Effective as of March 19, 2026 (the \"Repricing Date\"), the Issuer approved a one-time repricing of certain outstanding stock options (the \"Repriced Options\") granted under the Issuer's 2019 Incentive Award Plan (the \"2019 Plan\"), which reduced the per share exercise price of each Repriced Option to $0.45 (the \"Option Repricing\"). Except as modified by the Option Repricing, all other terms and conditions of the Repriced Options, including, without limitation, any provisions with respect to vesting and term of the Repriced Options, remain in full force and effect."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Effective as of March 19, 2026 (the \"Repricing Date\"), the Issuer approved a one-time repricing of certain outstanding stock options (the \"Repriced Options\") granted under the Issuer's 2019 Incentive Award Plan (the \"2019 Plan\"), which reduced the per share exercise price of each Repriced Option to $0.45 (the \"Option Repricing\"). Except as modified by the Option Repricing, all other terms and conditions of the Repriced Options, including, without limitation, any provisions with respect to vesting and term of the Repriced Options, remain in full force and effect."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the 2019 Plan and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form 4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":157500,"derivative":{"exercise_price":0.45,"expiration_date":"2033-03-19","underlying":"Common Stock","underlying_shares":157500},"source":{"system":"sec-edgar","filing":"0001867872-26-000004","document":"wk-form4_1774038115.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1728117/000186787226000004/wk-form4_1774038115.xml","form_type":"4"}},{"id":831925,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":56793,"kind":"person","name":"Aranda Richard","position":1,"cik":"0001867872","reported_name":"Aranda Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-20T20:22:00.000Z","date":"2026-03-19","kind":"grant","planned":false,"acquired":true,"shares":162500,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Effective as of March 19, 2026 (the \"Repricing Date\"), the Issuer approved a one-time repricing of certain outstanding stock options (the \"Repriced Options\") granted under the Issuer's 2019 Incentive Award Plan (the \"2019 Plan\"), which reduced the per share exercise price of each Repriced Option to $0.45 (the \"Option Repricing\"). Except as modified by the Option Repricing, all other terms and conditions of the Repriced Options, including, without limitation, any provisions with respect to vesting and term of the Repriced Options, remain in full force and effect."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Effective as of March 19, 2026 (the \"Repricing Date\"), the Issuer approved a one-time repricing of certain outstanding stock options (the \"Repriced Options\") granted under the Issuer's 2019 Incentive Award Plan (the \"2019 Plan\"), which reduced the per share exercise price of each Repriced Option to $0.45 (the \"Option Repricing\"). Except as modified by the Option Repricing, all other terms and conditions of the Repriced Options, including, without limitation, any provisions with respect to vesting and term of the Repriced Options, remain in full force and effect."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the 2019 Plan and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form 4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":162500,"derivative":{"exercise_price":0.45,"expiration_date":"2033-11-19","underlying":"Common Stock","underlying_shares":162500},"source":{"system":"sec-edgar","filing":"0001867872-26-000004","document":"wk-form4_1774038115.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1728117/000186787226000004/wk-form4_1774038115.xml","form_type":"4"}},{"id":831924,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":56793,"kind":"person","name":"Aranda Richard","position":1,"cik":"0001867872","reported_name":"Aranda Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-20T20:22:00.000Z","date":"2026-03-19","kind":"grant","planned":false,"acquired":true,"shares":487500,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Effective as of March 19, 2026 (the \"Repricing Date\"), the Issuer approved a one-time repricing of certain outstanding stock options (the \"Repriced Options\") granted under the Issuer's 2019 Incentive Award Plan (the \"2019 Plan\"), which reduced the per share exercise price of each Repriced Option to $0.45 (the \"Option Repricing\"). Except as modified by the Option Repricing, all other terms and conditions of the Repriced Options, including, without limitation, any provisions with respect to vesting and term of the Repriced Options, remain in full force and effect."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Effective as of March 19, 2026 (the \"Repricing Date\"), the Issuer approved a one-time repricing of certain outstanding stock options (the \"Repriced Options\") granted under the Issuer's 2019 Incentive Award Plan (the \"2019 Plan\"), which reduced the per share exercise price of each Repriced Option to $0.45 (the \"Option Repricing\"). Except as modified by the Option Repricing, all other terms and conditions of the Repriced Options, including, without limitation, any provisions with respect to vesting and term of the Repriced Options, remain in full force and effect."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the 2019 Plan and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form 4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":487500,"derivative":{"exercise_price":0.45,"expiration_date":"2034-01-01","underlying":"Common Stock","underlying_shares":487500},"source":{"system":"sec-edgar","filing":"0001867872-26-000004","document":"wk-form4_1774038115.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1728117/000186787226000004/wk-form4_1774038115.xml","form_type":"4"}},{"id":831923,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":56793,"kind":"person","name":"Aranda Richard","position":1,"cik":"0001867872","reported_name":"Aranda Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-20T20:22:00.000Z","date":"2026-03-19","kind":"grant","planned":false,"acquired":true,"shares":572000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Effective as of March 19, 2026 (the \"Repricing Date\"), the Issuer approved a one-time repricing of certain outstanding stock options (the \"Repriced Options\") granted under the Issuer's 2019 Incentive Award Plan (the \"2019 Plan\"), which reduced the per share exercise price of each Repriced Option to $0.45 (the \"Option Repricing\"). Except as modified by the Option Repricing, all other terms and conditions of the Repriced Options, including, without limitation, any provisions with respect to vesting and term of the Repriced Options, remain in full force and effect."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Effective as of March 19, 2026 (the \"Repricing Date\"), the Issuer approved a one-time repricing of certain outstanding stock options (the \"Repriced Options\") granted under the Issuer's 2019 Incentive Award Plan (the \"2019 Plan\"), which reduced the per share exercise price of each Repriced Option to $0.45 (the \"Option Repricing\"). Except as modified by the Option Repricing, all other terms and conditions of the Repriced Options, including, without limitation, any provisions with respect to vesting and term of the Repriced Options, remain in full force and effect."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the 2019 Plan and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form 4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":572000,"derivative":{"exercise_price":0.45,"expiration_date":"2035-03-03","underlying":"Common Stock","underlying_shares":572000},"source":{"system":"sec-edgar","filing":"0001867872-26-000004","document":"wk-form4_1774038115.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1728117/000186787226000004/wk-form4_1774038115.xml","form_type":"4"}},{"id":831922,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":56793,"kind":"person","name":"Aranda Richard","position":1,"cik":"0001867872","reported_name":"Aranda Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-20T20:22:00.000Z","date":"2026-03-19","kind":"grant","planned":false,"acquired":true,"shares":562500,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Effective as of March 19, 2026 (the \"Repricing Date\"), the Issuer approved a one-time repricing of certain outstanding stock options (the \"Repriced Options\") granted under the Issuer's 2019 Incentive Award Plan (the \"2019 Plan\"), which reduced the per share exercise price of each Repriced Option to $0.45 (the \"Option Repricing\"). Except as modified by the Option Repricing, all other terms and conditions of the Repriced Options, including, without limitation, any provisions with respect to vesting and term of the Repriced Options, remain in full force and effect."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Effective as of March 19, 2026 (the \"Repricing Date\"), the Issuer approved a one-time repricing of certain outstanding stock options (the \"Repriced Options\") granted under the Issuer's 2019 Incentive Award Plan (the \"2019 Plan\"), which reduced the per share exercise price of each Repriced Option to $0.45 (the \"Option Repricing\"). Except as modified by the Option Repricing, all other terms and conditions of the Repriced Options, including, without limitation, any provisions with respect to vesting and term of the Repriced Options, remain in full force and effect."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the 2019 Plan and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form 4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":562500,"derivative":{"exercise_price":0.45,"expiration_date":"2036-01-01","underlying":"Common Stock","underlying_shares":562500},"source":{"system":"sec-edgar","filing":"0001867872-26-000004","document":"wk-form4_1774038115.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1728117/000186787226000004/wk-form4_1774038115.xml","form_type":"4"}},{"id":831921,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":56793,"kind":"person","name":"Aranda Richard","position":1,"cik":"0001867872","reported_name":"Aranda Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-20T20:22:00.000Z","date":"2026-03-19","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":30000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Effective as of March 19, 2026 (the \"Repricing Date\"), the Issuer approved a one-time repricing of certain outstanding stock options (the \"Repriced Options\") granted under the Issuer's 2019 Incentive Award Plan (the \"2019 Plan\"), which reduced the per share exercise price of each Repriced Option to $0.45 (the \"Option Repricing\"). Except as modified by the Option Repricing, all other terms and conditions of the Repriced Options, including, without limitation, any provisions with respect to vesting and term of the Repriced Options, remain in full force and effect."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Effective as of March 19, 2026 (the \"Repricing Date\"), the Issuer approved a one-time repricing of certain outstanding stock options (the \"Repriced Options\") granted under the Issuer's 2019 Incentive Award Plan (the \"2019 Plan\"), which reduced the per share exercise price of each Repriced Option to $0.45 (the \"Option Repricing\"). Except as modified by the Option Repricing, all other terms and conditions of the Repriced Options, including, without limitation, any provisions with respect to vesting and term of the Repriced Options, remain in full force and effect."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the 2019 Plan and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form 4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":0,"derivative":{"exercise_price":1.36,"expiration_date":"2029-03-25","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001867872-26-000004","document":"wk-form4_1774038115.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1728117/000186787226000004/wk-form4_1774038115.xml","form_type":"4"}},{"id":831920,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":56793,"kind":"person","name":"Aranda Richard","position":1,"cik":"0001867872","reported_name":"Aranda Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-20T20:22:00.000Z","date":"2026-03-19","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":9167,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Effective as of March 19, 2026 (the \"Repricing Date\"), the Issuer approved a one-time repricing of certain outstanding stock options (the \"Repriced Options\") granted under the Issuer's 2019 Incentive Award Plan (the \"2019 Plan\"), which reduced the per share exercise price of each Repriced Option to $0.45 (the \"Option Repricing\"). Except as modified by the Option Repricing, all other terms and conditions of the Repriced Options, including, without limitation, any provisions with respect to vesting and term of the Repriced Options, remain in full force and effect."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Effective as of March 19, 2026 (the \"Repricing Date\"), the Issuer approved a one-time repricing of certain outstanding stock options (the \"Repriced Options\") granted under the Issuer's 2019 Incentive Award Plan (the \"2019 Plan\"), which reduced the per share exercise price of each Repriced Option to $0.45 (the \"Option Repricing\"). Except as modified by the Option Repricing, all other terms and conditions of the Repriced Options, including, without limitation, any provisions with respect to vesting and term of the Repriced Options, remain in full force and effect."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the 2019 Plan and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form 4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":0,"derivative":{"exercise_price":1.36,"expiration_date":"2029-12-23","underlying":"Common Stock","underlying_shares":9167},"source":{"system":"sec-edgar","filing":"0001867872-26-000004","document":"wk-form4_1774038115.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1728117/000186787226000004/wk-form4_1774038115.xml","form_type":"4"}},{"id":831919,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":56793,"kind":"person","name":"Aranda Richard","position":1,"cik":"0001867872","reported_name":"Aranda Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-20T20:22:00.000Z","date":"2026-03-19","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":22784,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Effective as of March 19, 2026 (the \"Repricing Date\"), the Issuer approved a one-time repricing of certain outstanding stock options (the \"Repriced Options\") granted under the Issuer's 2019 Incentive Award Plan (the \"2019 Plan\"), which reduced the per share exercise price of each Repriced Option to $0.45 (the \"Option Repricing\"). Except as modified by the Option Repricing, all other terms and conditions of the Repriced Options, including, without limitation, any provisions with respect to vesting and term of the Repriced Options, remain in full force and effect."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Effective as of March 19, 2026 (the \"Repricing Date\"), the Issuer approved a one-time repricing of certain outstanding stock options (the \"Repriced Options\") granted under the Issuer's 2019 Incentive Award Plan (the \"2019 Plan\"), which reduced the per share exercise price of each Repriced Option to $0.45 (the \"Option Repricing\"). Except as modified by the Option Repricing, all other terms and conditions of the Repriced Options, including, without limitation, any provisions with respect to vesting and term of the Repriced Options, remain in full force and effect."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the 2019 Plan and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form 4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":0,"derivative":{"exercise_price":1.36,"expiration_date":"2030-02-14","underlying":"Common Stock","underlying_shares":22784},"source":{"system":"sec-edgar","filing":"0001867872-26-000004","document":"wk-form4_1774038115.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1728117/000186787226000004/wk-form4_1774038115.xml","form_type":"4"}},{"id":831918,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":56793,"kind":"person","name":"Aranda Richard","position":1,"cik":"0001867872","reported_name":"Aranda Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-20T20:22:00.000Z","date":"2026-03-19","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":40000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Effective as of March 19, 2026 (the \"Repricing Date\"), the Issuer approved a one-time repricing of certain outstanding stock options (the \"Repriced Options\") granted under the Issuer's 2019 Incentive Award Plan (the \"2019 Plan\"), which reduced the per share exercise price of each Repriced Option to $0.45 (the \"Option Repricing\"). Except as modified by the Option Repricing, all other terms and conditions of the Repriced Options, including, without limitation, any provisions with respect to vesting and term of the Repriced Options, remain in full force and effect."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Effective as of March 19, 2026 (the \"Repricing Date\"), the Issuer approved a one-time repricing of certain outstanding stock options (the \"Repriced Options\") granted under the Issuer's 2019 Incentive Award Plan (the \"2019 Plan\"), which reduced the per share exercise price of each Repriced Option to $0.45 (the \"Option Repricing\"). Except as modified by the Option Repricing, all other terms and conditions of the Repriced Options, including, without limitation, any provisions with respect to vesting and term of the Repriced Options, remain in full force and effect."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the 2019 Plan and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form 4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":0,"derivative":{"exercise_price":1.36,"expiration_date":"2031-02-25","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001867872-26-000004","document":"wk-form4_1774038115.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1728117/000186787226000004/wk-form4_1774038115.xml","form_type":"4"}},{"id":831917,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":56793,"kind":"person","name":"Aranda Richard","position":1,"cik":"0001867872","reported_name":"Aranda Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-20T20:22:00.000Z","date":"2026-03-19","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":20000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Effective as of March 19, 2026 (the \"Repricing Date\"), the Issuer approved a one-time repricing of certain outstanding stock options (the \"Repriced Options\") granted under the Issuer's 2019 Incentive Award Plan (the \"2019 Plan\"), which reduced the per share exercise price of each Repriced Option to $0.45 (the \"Option Repricing\"). Except as modified by the Option Repricing, all other terms and conditions of the Repriced Options, including, without limitation, any provisions with respect to vesting and term of the Repriced Options, remain in full force and effect."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Effective as of March 19, 2026 (the \"Repricing Date\"), the Issuer approved a one-time repricing of certain outstanding stock options (the \"Repriced Options\") granted under the Issuer's 2019 Incentive Award Plan (the \"2019 Plan\"), which reduced the per share exercise price of each Repriced Option to $0.45 (the \"Option Repricing\"). Except as modified by the Option Repricing, all other terms and conditions of the Repriced Options, including, without limitation, any provisions with respect to vesting and term of the Repriced Options, remain in full force and effect."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the 2019 Plan and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form 4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":0,"derivative":{"exercise_price":1.36,"expiration_date":"2031-06-21","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001867872-26-000004","document":"wk-form4_1774038115.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1728117/000186787226000004/wk-form4_1774038115.xml","form_type":"4"}},{"id":831916,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":56793,"kind":"person","name":"Aranda Richard","position":1,"cik":"0001867872","reported_name":"Aranda Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-20T20:22:00.000Z","date":"2026-03-19","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":126667,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Effective as of March 19, 2026 (the \"Repricing Date\"), the Issuer approved a one-time repricing of certain outstanding stock options (the \"Repriced Options\") granted under the Issuer's 2019 Incentive Award Plan (the \"2019 Plan\"), which reduced the per share exercise price of each Repriced Option to $0.45 (the \"Option Repricing\"). Except as modified by the Option Repricing, all other terms and conditions of the Repriced Options, including, without limitation, any provisions with respect to vesting and term of the Repriced Options, remain in full force and effect."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Effective as of March 19, 2026 (the \"Repricing Date\"), the Issuer approved a one-time repricing of certain outstanding stock options (the \"Repriced Options\") granted under the Issuer's 2019 Incentive Award Plan (the \"2019 Plan\"), which reduced the per share exercise price of each Repriced Option to $0.45 (the \"Option Repricing\"). Except as modified by the Option Repricing, all other terms and conditions of the Repriced Options, including, without limitation, any provisions with respect to vesting and term of the Repriced Options, remain in full force and effect."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the 2019 Plan and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form 4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":0,"derivative":{"exercise_price":1.36,"expiration_date":"2032-01-05","underlying":"Common Stock","underlying_shares":126667},"source":{"system":"sec-edgar","filing":"0001867872-26-000004","document":"wk-form4_1774038115.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1728117/000186787226000004/wk-form4_1774038115.xml","form_type":"4"}},{"id":831915,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":56793,"kind":"person","name":"Aranda Richard","position":1,"cik":"0001867872","reported_name":"Aranda Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-20T20:22:00.000Z","date":"2026-03-19","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":157500,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Effective as of March 19, 2026 (the \"Repricing Date\"), the Issuer approved a one-time repricing of certain outstanding stock options (the \"Repriced Options\") granted under the Issuer's 2019 Incentive Award Plan (the \"2019 Plan\"), which reduced the per share exercise price of each Repriced Option to $0.45 (the \"Option Repricing\"). Except as modified by the Option Repricing, all other terms and conditions of the Repriced Options, including, without limitation, any provisions with respect to vesting and term of the Repriced Options, remain in full force and effect."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Effective as of March 19, 2026 (the \"Repricing Date\"), the Issuer approved a one-time repricing of certain outstanding stock options (the \"Repriced Options\") granted under the Issuer's 2019 Incentive Award Plan (the \"2019 Plan\"), which reduced the per share exercise price of each Repriced Option to $0.45 (the \"Option Repricing\"). Except as modified by the Option Repricing, all other terms and conditions of the Repriced Options, including, without limitation, any provisions with respect to vesting and term of the Repriced Options, remain in full force and effect."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the 2019 Plan and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form 4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":0,"derivative":{"exercise_price":2.16,"expiration_date":"2032-12-06","underlying":"Common Stock","underlying_shares":157500},"source":{"system":"sec-edgar","filing":"0001867872-26-000004","document":"wk-form4_1774038115.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1728117/000186787226000004/wk-form4_1774038115.xml","form_type":"4"}},{"id":831914,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":56793,"kind":"person","name":"Aranda Richard","position":1,"cik":"0001867872","reported_name":"Aranda Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-20T20:22:00.000Z","date":"2026-03-19","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":157500,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Effective as of March 19, 2026 (the \"Repricing Date\"), the Issuer approved a one-time repricing of certain outstanding stock options (the \"Repriced Options\") granted under the Issuer's 2019 Incentive Award Plan (the \"2019 Plan\"), which reduced the per share exercise price of each Repriced Option to $0.45 (the \"Option Repricing\"). Except as modified by the Option Repricing, all other terms and conditions of the Repriced Options, including, without limitation, any provisions with respect to vesting and term of the Repriced Options, remain in full force and effect."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Effective as of March 19, 2026 (the \"Repricing Date\"), the Issuer approved a one-time repricing of certain outstanding stock options (the \"Repriced Options\") granted under the Issuer's 2019 Incentive Award Plan (the \"2019 Plan\"), which reduced the per share exercise price of each Repriced Option to $0.45 (the \"Option Repricing\"). Except as modified by the Option Repricing, all other terms and conditions of the Repriced Options, including, without limitation, any provisions with respect to vesting and term of the Repriced Options, remain in full force and effect."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the 2019 Plan and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form 4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":0,"derivative":{"exercise_price":1.21,"expiration_date":"2033-03-19","underlying":"Common Stock","underlying_shares":157500},"source":{"system":"sec-edgar","filing":"0001867872-26-000004","document":"wk-form4_1774038115.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1728117/000186787226000004/wk-form4_1774038115.xml","form_type":"4"}},{"id":831913,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":56793,"kind":"person","name":"Aranda Richard","position":1,"cik":"0001867872","reported_name":"Aranda Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-20T20:22:00.000Z","date":"2026-03-19","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":162500,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Effective as of March 19, 2026 (the \"Repricing Date\"), the Issuer approved a one-time repricing of certain outstanding stock options (the \"Repriced Options\") granted under the Issuer's 2019 Incentive Award Plan (the \"2019 Plan\"), which reduced the per share exercise price of each Repriced Option to $0.45 (the \"Option Repricing\"). Except as modified by the Option Repricing, all other terms and conditions of the Repriced Options, including, without limitation, any provisions with respect to vesting and term of the Repriced Options, remain in full force and effect."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Effective as of March 19, 2026 (the \"Repricing Date\"), the Issuer approved a one-time repricing of certain outstanding stock options (the \"Repriced Options\") granted under the Issuer's 2019 Incentive Award Plan (the \"2019 Plan\"), which reduced the per share exercise price of each Repriced Option to $0.45 (the \"Option Repricing\"). Except as modified by the Option Repricing, all other terms and conditions of the Repriced Options, including, without limitation, any provisions with respect to vesting and term of the Repriced Options, remain in full force and effect."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the 2019 Plan and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form 4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":0,"derivative":{"exercise_price":0.838,"expiration_date":"2033-11-19","underlying":"Common Stock","underlying_shares":162500},"source":{"system":"sec-edgar","filing":"0001867872-26-000004","document":"wk-form4_1774038115.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1728117/000186787226000004/wk-form4_1774038115.xml","form_type":"4"}},{"id":831912,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":56793,"kind":"person","name":"Aranda Richard","position":1,"cik":"0001867872","reported_name":"Aranda Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-20T20:22:00.000Z","date":"2026-03-19","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":487500,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Effective as of March 19, 2026 (the \"Repricing Date\"), the Issuer approved a one-time repricing of certain outstanding stock options (the \"Repriced Options\") granted under the Issuer's 2019 Incentive Award Plan (the \"2019 Plan\"), which reduced the per share exercise price of each Repriced Option to $0.45 (the \"Option Repricing\"). Except as modified by the Option Repricing, all other terms and conditions of the Repriced Options, including, without limitation, any provisions with respect to vesting and term of the Repriced Options, remain in full force and effect."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Effective as of March 19, 2026 (the \"Repricing Date\"), the Issuer approved a one-time repricing of certain outstanding stock options (the \"Repriced Options\") granted under the Issuer's 2019 Incentive Award Plan (the \"2019 Plan\"), which reduced the per share exercise price of each Repriced Option to $0.45 (the \"Option Repricing\"). Except as modified by the Option Repricing, all other terms and conditions of the Repriced Options, including, without limitation, any provisions with respect to vesting and term of the Repriced Options, remain in full force and effect."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the 2019 Plan and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form 4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":0,"derivative":{"exercise_price":0.97,"expiration_date":"2034-01-01","underlying":"Common Stock","underlying_shares":487500},"source":{"system":"sec-edgar","filing":"0001867872-26-000004","document":"wk-form4_1774038115.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1728117/000186787226000004/wk-form4_1774038115.xml","form_type":"4"}},{"id":831911,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":56793,"kind":"person","name":"Aranda Richard","position":1,"cik":"0001867872","reported_name":"Aranda Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-20T20:22:00.000Z","date":"2026-03-19","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":572000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Effective as of March 19, 2026 (the \"Repricing Date\"), the Issuer approved a one-time repricing of certain outstanding stock options (the \"Repriced Options\") granted under the Issuer's 2019 Incentive Award Plan (the \"2019 Plan\"), which reduced the per share exercise price of each Repriced Option to $0.45 (the \"Option Repricing\"). Except as modified by the Option Repricing, all other terms and conditions of the Repriced Options, including, without limitation, any provisions with respect to vesting and term of the Repriced Options, remain in full force and effect."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Effective as of March 19, 2026 (the \"Repricing Date\"), the Issuer approved a one-time repricing of certain outstanding stock options (the \"Repriced Options\") granted under the Issuer's 2019 Incentive Award Plan (the \"2019 Plan\"), which reduced the per share exercise price of each Repriced Option to $0.45 (the \"Option Repricing\"). Except as modified by the Option Repricing, all other terms and conditions of the Repriced Options, including, without limitation, any provisions with respect to vesting and term of the Repriced Options, remain in full force and effect."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the 2019 Plan and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form 4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":0,"derivative":{"exercise_price":1.13,"expiration_date":"2035-03-03","underlying":"Common Stock","underlying_shares":572000},"source":{"system":"sec-edgar","filing":"0001867872-26-000004","document":"wk-form4_1774038115.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1728117/000186787226000004/wk-form4_1774038115.xml","form_type":"4"}},{"id":831910,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":56793,"kind":"person","name":"Aranda Richard","position":1,"cik":"0001867872","reported_name":"Aranda Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-20T20:22:00.000Z","date":"2026-03-19","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":562500,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Effective as of March 19, 2026 (the \"Repricing Date\"), the Issuer approved a one-time repricing of certain outstanding stock options (the \"Repriced Options\") granted under the Issuer's 2019 Incentive Award Plan (the \"2019 Plan\"), which reduced the per share exercise price of each Repriced Option to $0.45 (the \"Option Repricing\"). Except as modified by the Option Repricing, all other terms and conditions of the Repriced Options, including, without limitation, any provisions with respect to vesting and term of the Repriced Options, remain in full force and effect."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Effective as of March 19, 2026 (the \"Repricing Date\"), the Issuer approved a one-time repricing of certain outstanding stock options (the \"Repriced Options\") granted under the Issuer's 2019 Incentive Award Plan (the \"2019 Plan\"), which reduced the per share exercise price of each Repriced Option to $0.45 (the \"Option Repricing\"). Except as modified by the Option Repricing, all other terms and conditions of the Repriced Options, including, without limitation, any provisions with respect to vesting and term of the Repriced Options, remain in full force and effect."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the 2019 Plan and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form 4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":0,"derivative":{"exercise_price":2.88,"expiration_date":"2036-01-01","underlying":"Common Stock","underlying_shares":562500},"source":{"system":"sec-edgar","filing":"0001867872-26-000004","document":"wk-form4_1774038115.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1728117/000186787226000004/wk-form4_1774038115.xml","form_type":"4"}},{"id":949842,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":56793,"kind":"person","name":"Aranda Richard","position":1,"cik":"0001867872","reported_name":"Aranda Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-01-05T21:38:14.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":562500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the total number of shares subject to the option will vest on January 2, 2027 and 1/48th of the total number of shares subject to the option vest on the last day of each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on each such vesting date."}],"balance_after":562500,"derivative":{"exercise_price":2.88,"expiration_date":"2036-01-01","underlying":"Common Stock","underlying_shares":562500},"source":{"system":"sec-edgar","filing":"0001867872-26-000002","document":"wk-form4_1767649091.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1728117/000186787226000002/wk-form4_1767649091.xml","form_type":"4"}},{"id":949841,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":56793,"kind":"person","name":"Aranda Richard","position":1,"cik":"0001867872","reported_name":"Aranda Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-01-05T21:38:14.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":93750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock unit award, which will vest in four equal annual installments in accordance with the terms of the award and subject to the Reporting Person's continuous service to the Issuer on each vesting date."}],"balance_after":463106,"source":{"system":"sec-edgar","filing":"0001867872-26-000002","document":"wk-form4_1767649091.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1728117/000186787226000002/wk-form4_1767649091.xml","form_type":"4"}},{"id":1026437,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":56793,"kind":"person","name":"Aranda Richard","position":1,"cik":"0001867872","reported_name":"Aranda Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-10-02T20:13:26.000Z","date":"2025-10-01","kind":"grant","planned":false,"acquired":true,"shares":162500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents performance stock unit award, which will vest in full upon the earlier of (i) the approval of a new drug application for seralutinib or (ii) a change in control, in either case on or prior to the fourth anniversary of the grant date, and subject to the Reporting Person's continuous service to the Issuer."}],"balance_after":369356,"source":{"system":"sec-edgar","filing":"0001867872-25-000003","document":"wk-form4_1759436003.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1728117/000186787225000003/wk-form4_1759436003.xml","form_type":"4"}},{"id":1218931,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":56793,"kind":"person","name":"Aranda Richard","position":1,"cik":"0001867872","reported_name":"Aranda Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-03-06T21:05:50.000Z","date":"2025-03-04","kind":"grant","planned":false,"acquired":true,"shares":572000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the total number of shares subject to the option will vest on March 4, 2026 and 1/48th of the total number of shares subject to the option vest on the last day of each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on each such vesting date."}],"balance_after":572000,"derivative":{"exercise_price":1.13,"expiration_date":"2035-03-03","underlying":"Common Stock","underlying_shares":572000},"source":{"system":"sec-edgar","filing":"0001728117-25-000012","document":"wk-form4_1741295144.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1728117/000172811725000012/wk-form4_1741295144.xml","form_type":"4"}},{"id":1469291,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":56793,"kind":"person","name":"Aranda Richard","position":1,"cik":"0001867872","reported_name":"Aranda Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2024-06-25T22:24:48.000Z","date":"2024-06-24","kind":"sale","planned":false,"acquired":false,"shares":1908,"price":0.6605,"value":1260.234,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a broker-assisted sale to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock units."}],"balance_after":196891,"source":{"system":"sec-edgar","filing":"0001728117-24-000078","document":"wk-form4_1719354282.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1728117/000172811724000078/wk-form4_1719354282.xml","form_type":"4"}},{"id":1567106,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":56793,"kind":"person","name":"Aranda Richard","position":1,"cik":"0001867872","reported_name":"Aranda Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2024-03-19T22:50:59.000Z","date":"2024-03-18","kind":"sale","planned":false,"acquired":false,"shares":4018,"price":1.3295,"value":5341.931,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a broker-assisted sale to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $1.329 to $1.331 per share. The price reported above reflects the weighted average sale price for the entire number of shares sold. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."}],"balance_after":198799,"source":{"system":"sec-edgar","filing":"0001728117-24-000034","document":"wk-form4_1710888644.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1728117/000172811724000034/wk-form4_1710888644.xml","form_type":"4"}},{"id":1686851,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":56793,"kind":"person","name":"Aranda Richard","position":1,"cik":"0001867872","reported_name":"Aranda Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-01-04T22:04:55.000Z","date":"2024-01-02","kind":"grant","planned":false,"acquired":true,"shares":487500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the total number of shares subject to the option will vest on January 2, 2025 and 1/48th of the total number of shares subject to the option vest on the last day of each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on each such vesting date."}],"balance_after":487500,"derivative":{"exercise_price":0.97,"expiration_date":"2034-01-01","underlying":"Common Stock","underlying_shares":487500},"source":{"system":"sec-edgar","filing":"0001728117-24-000006","document":"wk-form4_1704405870.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1728117/000172811724000006/wk-form4_1704405870.xml","form_type":"4"}},{"id":1730719,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":56793,"kind":"person","name":"Aranda Richard","position":1,"cik":"0001867872","reported_name":"Aranda Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-11-23T00:07:56.000Z","date":"2023-11-20","kind":"grant","planned":false,"acquired":true,"shares":162500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the total number of shares subject to the option will vest on November 20, 2024 and 1/48th of the total number of shares subject to the option vest on the last day of each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on each such vesting date."}],"balance_after":162500,"derivative":{"exercise_price":0.838,"expiration_date":"2033-11-19","underlying":"Common Stock","underlying_shares":162500},"source":{"system":"sec-edgar","filing":"0001728117-23-000148","document":"wk-form4_1700698065.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1728117/000172811723000148/wk-form4_1700698065.xml","form_type":"4"}},{"id":1844000,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":56793,"kind":"person","name":"Aranda Richard","position":1,"cik":"0001867872","reported_name":"Aranda Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-06-26T20:01:55.000Z","date":"2023-06-22","kind":"sale","planned":false,"acquired":false,"shares":1814,"price":1.29,"value":2340.06,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a broker-assisted sale to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $1.285 to 1.29 per share. The price reported above reflects the weighted average sale price for the entire number of shares sold. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."}],"balance_after":197574,"source":{"system":"sec-edgar","filing":"0001728117-23-000086","document":"wf-form4_168780970194929.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1728117/000172811723000086/wf-form4_168780970194929.xml","form_type":"4"}},{"id":1899133,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":56793,"kind":"person","name":"Aranda Richard","position":1,"cik":"0001867872","reported_name":"Aranda Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-05-09T20:22:19.000Z","date":"2023-05-05","kind":"grant","planned":false,"acquired":true,"shares":126667,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F13","text":"The exercise price of the option is $1.36 per share, representing the fair market value per share of the Issuer's common stock on the date of grant; provided that in the event the option is exercised prior to May 5, 2024, or the Reporting Person's employment terminates prior to May 5, 2024 other than due to death, disability or circumstances giving rise to severance under the Reporting Person's employment agreement, the exercise price will be increased to the exercise price of the cancelled option in exchange for which this option was granted."},{"field":"price","element":"transactionPricePerShare","label":"F12","text":"On May 5, 2023, the Issuer canceled an option granted on January 6, 2022. In exchange for the canceled option, the reporting person received 126,667 options to purchase common stock having a lower exercise price with the same vesting terms."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F11","text":"One-third of the total number of shares subject to the option vested on January 6, 2023 and 1/36th of the total number of shares subject to the option vest on the last day of each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on each such vesting date."}],"balance_after":126667,"derivative":{"exercise_price":1.36,"expiration_date":"2032-01-05","underlying":"Common Stock","underlying_shares":126667},"source":{"system":"sec-edgar","filing":"0001728117-23-000057","document":"wf-form4_168366370450924.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1728117/000172811723000057/wf-form4_168366370450924.xml","form_type":"4"}},{"id":1899132,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":56793,"kind":"person","name":"Aranda Richard","position":1,"cik":"0001867872","reported_name":"Aranda Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-05-09T20:22:19.000Z","date":"2023-05-05","kind":"grant","planned":false,"acquired":true,"shares":20000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F13","text":"The exercise price of the option is $1.36 per share, representing the fair market value per share of the Issuer's common stock on the date of grant; provided that in the event the option is exercised prior to May 5, 2024, or the Reporting Person's employment terminates prior to May 5, 2024 other than due to death, disability or circumstances giving rise to severance under the Reporting Person's employment agreement, the exercise price will be increased to the exercise price of the cancelled option in exchange for which this option was granted."},{"field":"price","element":"transactionPricePerShare","label":"F10","text":"On May 5, 2023, the Issuer canceled an option granted on June 21, 2021. In exchange for the canceled option, the reporting person received 20,000 options to purchase common stock having a lower exercise price with the same vesting terms."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"25% of the total number of shares subject to the option vested on June 21, 2022 and 1/48th of the total number of shares subject to the option vest on the last day of each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on each such vesting date."}],"balance_after":20000,"derivative":{"exercise_price":1.36,"expiration_date":"2031-06-21","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001728117-23-000057","document":"wf-form4_168366370450924.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1728117/000172811723000057/wf-form4_168366370450924.xml","form_type":"4"}},{"id":1899131,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":56793,"kind":"person","name":"Aranda Richard","position":1,"cik":"0001867872","reported_name":"Aranda Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-05-09T20:22:19.000Z","date":"2023-05-05","kind":"grant","planned":false,"acquired":true,"shares":40000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F13","text":"The exercise price of the option is $1.36 per share, representing the fair market value per share of the Issuer's common stock on the date of grant; provided that in the event the option is exercised prior to May 5, 2024, or the Reporting Person's employment terminates prior to May 5, 2024 other than due to death, disability or circumstances giving rise to severance under the Reporting Person's employment agreement, the exercise price will be increased to the exercise price of the cancelled option in exchange for which this option was granted."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"On May 5, 2023, the Issuer canceled an option granted on February 25, 2021. In exchange for the canceled option, the reporting person received 40,000 options to purchase common stock having a lower exercise price with the same vesting terms."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"25% of the total number of shares subject to the option vested on February 25, 2022 and 1/48th of the total number of shares subject to the option vest on the last day of each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on each such vesting date."}],"balance_after":40000,"derivative":{"exercise_price":1.36,"expiration_date":"2031-02-25","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001728117-23-000057","document":"wf-form4_168366370450924.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1728117/000172811723000057/wf-form4_168366370450924.xml","form_type":"4"}},{"id":1899130,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":56793,"kind":"person","name":"Aranda Richard","position":1,"cik":"0001867872","reported_name":"Aranda Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-05-09T20:22:19.000Z","date":"2023-05-05","kind":"grant","planned":false,"acquired":true,"shares":22784,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F13","text":"The exercise price of the option is $1.36 per share, representing the fair market value per share of the Issuer's common stock on the date of grant; provided that in the event the option is exercised prior to May 5, 2024, or the Reporting Person's employment terminates prior to May 5, 2024 other than due to death, disability or circumstances giving rise to severance under the Reporting Person's employment agreement, the exercise price will be increased to the exercise price of the cancelled option in exchange for which this option was granted."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"On May 5, 2023, the Issuer canceled an option granted on February 14, 2020. In exchange for the canceled option, the reporting person received 22,784 options to purchase common stock having a lower exercise price with the same vesting terms."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"25% of the total number of shares subject to the option vested on February 14, 2021 and 1/48th of the total number of shares subject to the option vest on the last day of each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on each such vesting date."}],"balance_after":22784,"derivative":{"exercise_price":1.36,"expiration_date":"2030-02-14","underlying":"Common Stock","underlying_shares":22784},"source":{"system":"sec-edgar","filing":"0001728117-23-000057","document":"wf-form4_168366370450924.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1728117/000172811723000057/wf-form4_168366370450924.xml","form_type":"4"}},{"id":1899129,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":56793,"kind":"person","name":"Aranda Richard","position":1,"cik":"0001867872","reported_name":"Aranda Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-05-09T20:22:19.000Z","date":"2023-05-05","kind":"grant","planned":false,"acquired":true,"shares":9167,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F13","text":"The exercise price of the option is $1.36 per share, representing the fair market value per share of the Issuer's common stock on the date of grant; provided that in the event the option is exercised prior to May 5, 2024, or the Reporting Person's employment terminates prior to May 5, 2024 other than due to death, disability or circumstances giving rise to severance under the Reporting Person's employment agreement, the exercise price will be increased to the exercise price of the cancelled option in exchange for which this option was granted."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"On May 5, 2023, the Issuer canceled an option granted on December 23, 2019. In exchange for the canceled option, the reporting person received 9,167 options to purchase common stock having a lower exercise price with the same vesting terms."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the total number of shares subject to the option vested on December 23, 2020 and 1/48th of the total number of shares subject to the option vest on the last day of each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on each such vesting date."}],"balance_after":9167,"derivative":{"exercise_price":1.36,"expiration_date":"2029-12-23","underlying":"Common Stock","underlying_shares":9167},"source":{"system":"sec-edgar","filing":"0001728117-23-000057","document":"wf-form4_168366370450924.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1728117/000172811723000057/wf-form4_168366370450924.xml","form_type":"4"}},{"id":1899128,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":56793,"kind":"person","name":"Aranda Richard","position":1,"cik":"0001867872","reported_name":"Aranda Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-05-09T20:22:19.000Z","date":"2023-05-05","kind":"grant","planned":false,"acquired":true,"shares":30000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F13","text":"The exercise price of the option is $1.36 per share, representing the fair market value per share of the Issuer's common stock on the date of grant; provided that in the event the option is exercised prior to May 5, 2024, or the Reporting Person's employment terminates prior to May 5, 2024 other than due to death, disability or circumstances giving rise to severance under the Reporting Person's employment agreement, the exercise price will be increased to the exercise price of the cancelled option in exchange for which this option was granted."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On May 5, 2023, the Issuer canceled an option granted on March 25, 2019. In exchange for the canceled option, the reporting person received 30,000 options to purchase common stock having a lower exercise price with the same vesting terms."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option are fully vested."}],"balance_after":30000,"derivative":{"exercise_price":1.36,"expiration_date":"2029-03-25","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001728117-23-000057","document":"wf-form4_168366370450924.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1728117/000172811723000057/wf-form4_168366370450924.xml","form_type":"4"}},{"id":1899127,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":56793,"kind":"person","name":"Aranda Richard","position":1,"cik":"0001867872","reported_name":"Aranda Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-05-09T20:22:19.000Z","date":"2023-05-05","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":190000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F12","text":"On May 5, 2023, the Issuer canceled an option granted on January 6, 2022. In exchange for the canceled option, the reporting person received 126,667 options to purchase common stock having a lower exercise price with the same vesting terms."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F11","text":"One-third of the total number of shares subject to the option vested on January 6, 2023 and 1/36th of the total number of shares subject to the option vest on the last day of each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on each such vesting date."}],"balance_after":0,"derivative":{"exercise_price":11.94,"expiration_date":"2032-01-05","underlying":"Common Stock","underlying_shares":190000},"source":{"system":"sec-edgar","filing":"0001728117-23-000057","document":"wf-form4_168366370450924.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1728117/000172811723000057/wf-form4_168366370450924.xml","form_type":"4"}},{"id":1899126,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":56793,"kind":"person","name":"Aranda Richard","position":1,"cik":"0001867872","reported_name":"Aranda Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-05-09T20:22:19.000Z","date":"2023-05-05","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":30000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F10","text":"On May 5, 2023, the Issuer canceled an option granted on June 21, 2021. In exchange for the canceled option, the reporting person received 20,000 options to purchase common stock having a lower exercise price with the same vesting terms."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"25% of the total number of shares subject to the option vested on June 21, 2022 and 1/48th of the total number of shares subject to the option vest on the last day of each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on each such vesting date."}],"balance_after":0,"derivative":{"exercise_price":8.47,"expiration_date":"2031-06-21","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001728117-23-000057","document":"wf-form4_168366370450924.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1728117/000172811723000057/wf-form4_168366370450924.xml","form_type":"4"}},{"id":1899125,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":56793,"kind":"person","name":"Aranda Richard","position":1,"cik":"0001867872","reported_name":"Aranda Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-05-09T20:22:19.000Z","date":"2023-05-05","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":60000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F8","text":"On May 5, 2023, the Issuer canceled an option granted on February 25, 2021. In exchange for the canceled option, the reporting person received 40,000 options to purchase common stock having a lower exercise price with the same vesting terms."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"25% of the total number of shares subject to the option vested on February 25, 2022 and 1/48th of the total number of shares subject to the option vest on the last day of each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on each such vesting date."}],"balance_after":0,"derivative":{"exercise_price":9.79,"expiration_date":"2031-02-25","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001728117-23-000057","document":"wf-form4_168366370450924.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1728117/000172811723000057/wf-form4_168366370450924.xml","form_type":"4"}},{"id":1899124,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":56793,"kind":"person","name":"Aranda Richard","position":1,"cik":"0001867872","reported_name":"Aranda Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-05-09T20:22:19.000Z","date":"2023-05-05","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":34175,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"On May 5, 2023, the Issuer canceled an option granted on February 14, 2020. In exchange for the canceled option, the reporting person received 22,784 options to purchase common stock having a lower exercise price with the same vesting terms."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"25% of the total number of shares subject to the option vested on February 14, 2021 and 1/48th of the total number of shares subject to the option vest on the last day of each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on each such vesting date."}],"balance_after":0,"derivative":{"exercise_price":14.55,"expiration_date":"2030-02-14","underlying":"Common Stock","underlying_shares":34175},"source":{"system":"sec-edgar","filing":"0001728117-23-000057","document":"wf-form4_168366370450924.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1728117/000172811723000057/wf-form4_168366370450924.xml","form_type":"4"}},{"id":1899123,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":56793,"kind":"person","name":"Aranda Richard","position":1,"cik":"0001867872","reported_name":"Aranda Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-05-09T20:22:19.000Z","date":"2023-05-05","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":13750,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"On May 5, 2023, the Issuer canceled an option granted on December 23, 2019. In exchange for the canceled option, the reporting person received 9,167 options to purchase common stock having a lower exercise price with the same vesting terms."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the total number of shares subject to the option vested on December 23, 2020 and 1/48th of the total number of shares subject to the option vest on the last day of each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on each such vesting date."}],"balance_after":0,"derivative":{"exercise_price":16.4,"expiration_date":"2029-12-23","underlying":"Common Stock","underlying_shares":13750},"source":{"system":"sec-edgar","filing":"0001728117-23-000057","document":"wf-form4_168366370450924.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1728117/000172811723000057/wf-form4_168366370450924.xml","form_type":"4"}},{"id":1899122,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":56793,"kind":"person","name":"Aranda Richard","position":1,"cik":"0001867872","reported_name":"Aranda Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-05-09T20:22:19.000Z","date":"2023-05-05","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":45000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On May 5, 2023, the Issuer canceled an option granted on March 25, 2019. In exchange for the canceled option, the reporting person received 30,000 options to purchase common stock having a lower exercise price with the same vesting terms."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option are fully vested."}],"balance_after":0,"derivative":{"exercise_price":22.1,"expiration_date":"2029-03-25","underlying":"Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001728117-23-000057","document":"wf-form4_168366370450924.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1728117/000172811723000057/wf-form4_168366370450924.xml","form_type":"4"}},{"id":1941132,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":56793,"kind":"person","name":"Aranda Richard","position":1,"cik":"0001867872","reported_name":"Aranda Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-03-22T21:20:07.000Z","date":"2023-03-20","kind":"grant","planned":false,"acquired":true,"shares":157500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the total number of shares subject to the option will vest on March 20, 2024 and 1/48th of the total number of shares subject to the option vest on the last day of each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on each such vesting date."}],"balance_after":157500,"derivative":{"exercise_price":1.21,"expiration_date":"2033-03-19","underlying":"Common Stock","underlying_shares":157500},"source":{"system":"sec-edgar","filing":"0001728117-23-000024","document":"wf-form4_167951999562246.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1728117/000172811723000024/wf-form4_167951999562246.xml","form_type":"4"}},{"id":1944099,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":56793,"kind":"person","name":"Aranda Richard","position":1,"cik":"0001867872","reported_name":"Aranda Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-03-20T13:21:15.000Z","date":"2023-03-16","kind":"sale","planned":false,"acquired":false,"shares":7563,"price":1.098,"value":8304.174,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a broker-assisted sale to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $1.08 to $1.10 per share. The price reported above reflects the weighted average sale price for the entire number of shares sold. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."}],"balance_after":199388,"source":{"system":"sec-edgar","filing":"0001728117-23-000014","document":"wf-form4_167931846505758.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1728117/000172811723000014/wf-form4_167931846505758.xml","form_type":"4"}},{"id":2090752,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":56793,"kind":"person","name":"Aranda Richard","position":1,"cik":"0001867872","reported_name":"Aranda Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-12-09T22:18:58.000Z","date":"2022-12-07","kind":"grant","acquired":true,"shares":157500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-third of the total number of shares subject to the option will vest on December 7, 2023 and 1/36th of the total number of shares subject to the option vest on the last day of each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on each such vesting date."}],"balance_after":157500,"derivative":{"exercise_price":2.16,"expiration_date":"2032-12-06","underlying":"Common Stock","underlying_shares":157500},"source":{"system":"sec-edgar","filing":"0001728117-22-000110","document":"wf-form4_167062432335745.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1728117/000172811722000110/wf-form4_167062432335745.xml","form_type":"4"}},{"id":2132149,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":56793,"kind":"person","name":"Aranda Richard","position":1,"cik":"0001867872","reported_name":"Aranda Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2022-10-25T20:55:44.000Z","date":"2022-10-24","kind":"sale","acquired":false,"shares":4757,"price":12.073,"value":57431.261,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a broker-assisted sale to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $11.881 to $12.078 per share. The price reported above reflects the weighted average sale price for the entire number of shares sold.Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."}],"balance_after":205430,"source":{"system":"sec-edgar","filing":"0001728117-22-000088","document":"wf-form4_166673132619628.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1728117/000172811722000088/wf-form4_166673132619628.xml","form_type":"4"}},{"id":2222690,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":56793,"kind":"person","name":"Aranda Richard","position":1,"cik":"0001867872","reported_name":"Aranda Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2022-06-23T22:47:07.000Z","date":"2022-06-22","kind":"sale","acquired":false,"shares":1778,"price":6.88,"value":12232.64,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a broker-assisted sale to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $6.88 to 7.13 per share. The price reported above reflects the weighted average sale price for the entire number of shares sold. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."}],"balance_after":209897,"source":{"system":"sec-edgar","filing":"0001728117-22-000051","document":"wf-form4_165602440770532.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1728117/000172811722000051/wf-form4_165602440770532.xml","form_type":"4"}},{"id":2326026,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":56793,"kind":"person","name":"Aranda Richard","position":1,"cik":"0001867872","reported_name":"Aranda Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2022-03-17T20:58:08.000Z","date":"2022-03-16","kind":"sale","acquired":false,"shares":6278,"price":8.279,"value":51975.562,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a broker-assisted sale to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $8.27 to $8.42 per share. The price reported above reflects the weighted average sale price for the entire number of shares sold. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."}],"balance_after":211675,"source":{"system":"sec-edgar","filing":"0001728117-22-000023","document":"wf-form4_164755066150082.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1728117/000172811722000023/wf-form4_164755066150082.xml","form_type":"4"}},{"id":2438627,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":56793,"kind":"person","name":"Aranda Richard","position":1,"cik":"0001867872","reported_name":"Aranda Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-01-10T21:09:33.000Z","date":"2022-01-06","kind":"grant","acquired":true,"shares":190000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-third of the total number of shares subject to the option will vest on January 6, 2023 and 1/36th of the total number of shares subject to the option vest on the last day of each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on each such vesting date."}],"balance_after":190000,"derivative":{"exercise_price":11.94,"expiration_date":"2032-01-05","underlying":"Common Stock","underlying_shares":190000},"source":{"system":"sec-edgar","filing":"0001728117-22-000007","document":"wf-form4_164184894330645.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1728117/000172811722000007/wf-form4_164184894330645.xml","form_type":"4"}},{"id":2534306,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":56793,"kind":"person","name":"Aranda Richard","position":1,"cik":"0001867872","reported_name":"Aranda Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-10-26T20:58:47.000Z","date":"2021-10-25","kind":"sale","acquired":false,"shares":2377,"price":12.25,"value":29118.25,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a broker-assisted sale to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock units."}],"balance_after":217432,"source":{"system":"sec-edgar","filing":"0001728117-21-000096","document":"wf-form4_163528190028614.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1728117/000172811721000096/wf-form4_163528190028614.xml","form_type":"4"}},{"id":2658195,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":56793,"kind":"person","name":"Aranda Richard","position":1,"cik":"0001867872","reported_name":"Aranda Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-23T00:13:19.000Z","date":"2021-06-21","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the total number of shares subject to the option will vest on June 21, 2022 and 1/48th of the total number of shares subject to the option vest on the last day of each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on each such vesting date."}],"balance_after":30000,"derivative":{"exercise_price":8.47,"expiration_date":"2031-06-21","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001728117-21-000078","document":"wf-form4_162440717118673.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1728117/000172811721000078/wf-form4_162440717118673.xml","form_type":"4"}},{"id":2658194,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":56793,"kind":"person","name":"Aranda Richard","position":1,"cik":"0001867872","reported_name":"Aranda Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-06-23T00:13:19.000Z","date":"2021-06-21","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a restricted stock unit award, which will vest in three equal annual installments in accordance with the terms of the award and subject to the Reporting Person's continuous service to the Issuer on each vesting date."}],"balance_after":219809,"source":{"system":"sec-edgar","filing":"0001728117-21-000078","document":"wf-form4_162440717118673.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1728117/000172811721000078/wf-form4_162440717118673.xml","form_type":"4"}}]}